(Q43784914)

26 November 2017

title

Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis (English)

1 reference

26 November 2017

1 reference

Huo TI

1

1 reference

26 November 2017

Wu JC

2

1 reference

26 November 2017

Lee PC

3

1 reference

26 November 2017

Chau GY

4

1 reference

26 November 2017

Lui WY

5

1 reference

26 November 2017

Tsay SH

6

1 reference

26 November 2017

Ting LT

7

1 reference

26 November 2017

Chang FY

8

1 reference

26 November 2017

Lee SD

9

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 July 1998

1 reference

26 November 2017

1 reference

26 November 2017

volume

28

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

231-236

1 reference

The Liver Histology and Frequency of Clearance of the Hepatitis B Surface Antigen (HBsAg) in Chronic Carriers

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Spontaneous hepatitis B surface antigen clearance in a long-term follow-up study of patients with chronic type B hepatitis. Lack of correlation with hepatitis C and D virus superinfection.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Natural history of liver disease in chronic hepatitis B surface antigen carriers. Survey of 100 patients from Great Britain

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Delayed HBsAg clearance in chronic hepatitis B viral infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

The Significance of Serologic, Histologic, and Immunohistologic Findings in the Prognosis of 88 Asymptomatic Carriers of Hepatitis B Surface Antigen

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

HBsAg clearance in chronic active hepatitis B. A possible cause of cryptogenic cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

HBsAg clearance in patients with long-standing chronic active hepatitis B and hepatitis B virus-induced liver cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Long-term follow-up study of asymptomatic HBsAg-positive voluntary blood donors in Austria: a clinical and histologic evaluation of 242 cases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Incidence of hepatitis B virus infections in preschool children in Taiwan.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Vertical Transmission of Hepatitis B Antigen in Taiwan

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Clearance of hepatitis B surface antigen (HBsAg) after surgical resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Clearance of HBsAg in seven patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Fulminant and subfulminant liver failure: definitions and causes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Hepatitis C and B viruses in hepatitis B surface antigen-negative hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Isolation of high-molecular-weight DNA from mammalian cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Prevalence, infectivity, and risk factor analysis of hepatitis C virus infection in prostitutes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Avoiding false positives with PCR

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Hepatitis C virus infection among patients with chronic liver disease in an area hyperendemic for hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

The significance of antibody to hepatitis C virus in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Hepatitis B virus DNA in serum and liver is commonly found in chinese patients with chronic liver disease despite the presence of antibodies to HBsAg

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Serum hepatitis C virus RNA and hepatitis B virus DNA in non-A, non-B post-transfusional and sporadic chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Immunodiagnosis of hepatitis B with high-affinity IgM monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Identification and transmission of hepatitis B virus-related variants

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Clinical study on primary carcinoma of the liver in Taiwan

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Comparison of clinico-pathological features in hepatitis B virus-associated hepatocellular carcinoma with or without hepatitis D virus superinfection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280130

7 January 2021

Identifiers

DOI

10.1002/HEP.510280130

1 reference

26 November 2017

1 reference